The Successful Treatment of Myeloperoxidase Antineutrophil Cytoplasmic Antibody-positive Hypertrophic Pachymeningitis in Patients with the Limited Form of Granulomatosis with Polyangiitis Using Methotrexate: Two Case Reports
-
- Kaieda Shinjiro
- Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Japan
-
- Yoshida Naomi
- Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Japan
-
- Minezaki Midori
- Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Japan
-
- Ushijima Shuri
- Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Japan
-
- Wakasugi Daisuke
- Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Japan
-
- Miura Shiroh
- Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Japan
-
- Uchiyama Yusuke
- Department of Radiology, Kurume University School of Medicine, Japan
-
- Ida Hiroaki
- Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Japan
-
- Hoshino Tomoaki
- Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Japan
Search this article
Abstract
<p>Recent findings have indicated a close relationship between myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-positive hypertrophic pachymeningitis and the limited form of granulomatosis with polyangiitis (GPA). In Japan, MPO-ANCA-positive hypertrophic pachymeningitis predominantly occurs in elderly individuals. We herein describe the cases of two patients with MPO-ANCA-positive hypertrophic pachymeningitis associated with the limited form of GPA who were successfully treated with a combination of corticosteroids and methotrexate. Although methotrexate has been shown to be less effective than cyclophosphamide for inducing the remission of GPA in patients with organ-threatening diseases, its safety and efficacy may make it a useful alternative treatment modality for patients with the limited form of GPA who show meningeal involvement. </p>
Journal
-
- Internal Medicine
-
Internal Medicine 56 (8), 959-965, 2017
The Japanese Society of Internal Medicine